Back to company

EIDORFF IMPLANTS ApS: Financial statements 2023

CVR: 11965482

EIDORFF IMPLANTS ApS (CVR 11965482) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 346,112 and a net result of DKK 947,737 compared with DKK -164,900 the year before. That is a decrease of 31.3% compared with the year before. Equity amounted to DKK 7,035,857. The solvency ratio was 83.8%. The company had 1 employee in the financial year.

Gross Profit
346,112 kr.
Profit/Loss
947,737 kr.
Equity
7,035,857 kr.
Total Assets
8,392,248 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-346 t.948 t.7 mio.1
2022-504 t.-165 t.6.1 mio.1
2021-450 t.-48 t.6.3 mio.0
2020--1 mio.-772 t.6.3 mio.0
2019-121 t.411 t.7.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

EIDORFF IMPLANTS ApS: The 2022 annual report is outJan 20, 2023

EIDORFF IMPLANTS ApS has published its annual report for 2022. Gross profit came to DKK 504,005, and the net result was DKK -164,900.

About EIDORFF IMPLANTS ApS

EIDORFF IMPLANTS ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 1987. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Anne Overgaard Eidorff and Henrik Skov. The company is owned by EIDORFF HOLDING ApS and Frederik Eidorff Holding ApS. The company has 3 employees. In 2025, the company reported a gross profit of DKK 1,082,430 and a net result of DKK -1,209 compared with DKK 5,790,995 the year before. Equity amounted to DKK 2,825,643.